Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-07

Clinical Trial Update: Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders [Phase 3]

View source ↗

Summary

Phase 3 trial update on Dual Ovarian Stimulation (DUOSTIM) for poor ovarian responders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Intercommunal Creteil | Conditions: Fertility Disorders | Phase 3 | Status: COMPLETED